|
Lescarden Inc |
Details
|
Lescarden, inc. focuses on research, testing and the development of drugs indicated to control and treat various diseases. Lescarden also licenses its technology for commercialization by other industries, as well as selling its bovine cartilage material: BIO-CARTILAGE, as a food supplement. In addition, Lescarden engages in the development of POLY-NAG to the over-the-counter food supplement market in terms of their cosmetic, therapeutic, and food supplement values. The company specializes in the development of: Catrix ointment, Catrix powder, Creams, as well as lip balm indicated for treatment of a multiplicity of topical wounds. Lescarden, inc. is based in New York City and is a publicly traded company under the stock symbol: LCAR.
|
| Category |
Pharmaceutical Companies > L
|
| Related Searches |
Catrix 5, LCAR Stock |
| Date Submitted |
22-Aug-2005
|
|
